Black Diamond Therapeutics, Inc. (BDTX)
USD 2.34
(-6.4%)
USD 2.34
(-6.4%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | 437 Thousand | 3.23 Million | 2.21 Million | 600 Thousand | 47 Thousand | 44 Thousand |
| Gross Profit | -437 Thousand | -3.23 Million | -2.21 Million | -600 Thousand | -47 Thousand | -44 Thousand |
| Operating Expenses | 86.46 Million | 92.82 Million | 126.87 Million | 69.57 Million | 29.33 Million | 8.9 Million |
| Selling, General and Administrative Expenses | 27.11 Million | 28.39 Million | 30.04 Million | 21.36 Million | 7.57 Million | 1.95 Million |
| Research and Development Expenses | 59.35 Million | 64.43 Million | 96.82 Million | 48.2 Million | 21.75 Million | 6.95 Million |
| Other Expenses | - | -354 Thousand | -2.18 Million | -1.72 Million | 6000.00 | -16 Thousand |
| Cost and Expenses | 86.46 Million | 92.82 Million | 126.87 Million | 69.57 Million | 29.33 Million | 8.9 Million |
| Operating Income | -86.46 Million | -92.82 Million | -126.87 Million | -69.57 Million | -8.9 Million | -8.9 Million |
| Interest Expense | - | - | - | 1000.00 | - | - |
| Income Tax Expense | - | -4.39 Million | -2.39 Million | -1.77 Million | 5.88 Million | -27 Thousand |
| Earnings before Tax | -82.44 Million | -88.91 Million | -125.59 Million | -67.25 Million | -35.25 Million | -8.93 Million |
| Net Income | -82.44 Million | -84.52 Million | -123.2 Million | -65.47 Million | -41.14 Million | -8.93 Million |
| Earnings Per Share Basic | -1.88 | -2.33 | -3.40 | -1.99 | -1.15 | -0.64 |
| Earnings Per Share Diluted | -1.88 | -2.33 | -3.40 | -1.99 | -1.15 | -0.64 |
| Weighted Average Shares Outstanding | 43.95 Million | 36.32 Million | 36.18 Million | 32.9 Million | 35.91 Million | 13.95 Million |
| Weighted Average Shares Outstanding (Diluted) | 43.95 Million | 36.32 Million | 36.18 Million | 32.9 Million | 35.91 Million | 13.95 Million |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -86.02 Million | -92.32 Million | -126.66 Million | -66.65 Million | -29.28 Million | -8.88 Million |
| Earnings Before Tax Margin | - | - | - | - | - | - |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | 4.89 Million | - |
| Cost of Revenue | - | 86 Thousand | 86 Thousand | 437 Thousand | 86 Thousand | 823 Thousand |
| Gross Profit | - | -86 Thousand | -86 Thousand | -437 Thousand | 4.8 Million | -823 Thousand |
| Operating Expenses | 18.13 Million | 22.04 Million | 20.16 Million | 86.02 Million | 20.76 Million | 24.01 Million |
| Selling, General and Administrative Expenses | 5.21 Million | 9.57 Million | 6.7 Million | - | 5.56 Million | 7.85 Million |
| Research and Development Expenses | 12.91 Million | 12.47 Million | 13.45 Million | - | 15.2 Million | 16.15 Million |
| Other Expenses | - | 1.75 Million | 1.38 Million | - | 1.12 Million | 566 Thousand |
| Cost and Expenses | 18.13 Million | 22.13 Million | 20.24 Million | 86.46 Million | 20.85 Million | 24.01 Million |
| Operating Income | -18.13 Million | -22.13 Million | -20.24 Million | -86.46 Million | -20.85 Million | -24.01 Million |
| Interest Expense | - | - | - | - | 686 Thousand | - |
| Income Tax Expense | - | - | 42.72 Thousand | - | 1.34 Million | -115 Thousand |
| Earnings before Tax | -15.55 Million | -19.9 Million | -18.22 Million | -82.44 Million | -19.4 Million | -23 Million |
| Net Income | -15.55 Million | -19.9 Million | -18.22 Million | -82.44 Million | -19.4 Million | -23 Million |
| Earnings Per Share Basic | -0.28 | -0.36 | -0.35 | - | -0.38 | -0.45 |
| Earnings Per Share Diluted | -0.28 | -0.36 | -0.35 | - | -0.38 | -0.45 |
| Weighted Average Shares Outstanding | 56.5 Million | 55.15 Million | 51.8 Million | 43.95 Million | 51.63 Million | 50.94 Million |
| Weighted Average Shares Outstanding (Diluted) | 56.5 Million | 55.15 Million | 51.8 Million | 43.95 Million | 51.63 Million | 50.94 Million |
| Gross Margin | - | - | - | - | 0.98 | - |
| EBIT Margin | - | - | - | - | -4.24 | - |
| Profit Margin | - | - | - | - | -3.97 | - |
| EBITDA | -18.13 Million | -22.04 Million | -20.16 Million | - | -20.76 Million | -24.01 Million |
| Earnings Before Tax Margin | - | - | - | - | -4.26 | - |
RNK
601228
HXCK
003029
ASTTF
SPOG